Important update for YFVC: latex and yellow fever vaccine
Sanofi Pasteur, the manufacturer of Stamaril yellow fever vaccine have update their product information (SmPC)
The SmPC for Stamaril yellow fever vaccine states that the tip caps of prefilled syringes contain a natural rubber latex derivative, which may cause allergic reactions in latex sensitive individuals. Stamaril is the only yellow fever vaccine currently available in the United Kingdom.
YFVC are reminded of the importance of taking a medical history before administering any vaccine (for yellow fever vaccine, it is required that a checklist, which details the traveller’s medical history, is completed by the traveller/health professional as part of the risk assessment for yellow fever vaccination). It is required that the manufacturer’s patient leaflet should be given to everyone receiving a yellow fever vaccine as part of the travel consultation.
Health professionals can see updates and view changes made to the SmPC for licensed medicines in the UK by registering with the electronic medicines compendium.
Resources
Reporting adverse events
Information on management and reporting of suspected adverse events or inadvertent administration following YF vaccination
NaTHNaC Training Portal
Yellow fever eLearning and more
Yellow Fever vaccination recommendation maps
